nodes	percent_of_prediction	percent_of_DWPC	metapath
Ephedrine—ACHE—Irinotecan—pancreatic cancer	0.441	0.624	CbGbCtD
Ephedrine—BCHE—Irinotecan—pancreatic cancer	0.266	0.376	CbGbCtD
Ephedrine—Nasal dryness—Sunitinib—pancreatic cancer	0.00717	0.0435	CcSEcCtD
Ephedrine—Cerebral haemorrhage—Erlotinib—pancreatic cancer	0.00591	0.0358	CcSEcCtD
Ephedrine—Lightheadedness—Tamoxifen—pancreatic cancer	0.00296	0.0179	CcSEcCtD
Ephedrine—Blood pressure increased—Sunitinib—pancreatic cancer	0.00283	0.0172	CcSEcCtD
Ephedrine—Angina pectoris—Tamoxifen—pancreatic cancer	0.00202	0.0123	CcSEcCtD
Ephedrine—Euphoric mood—Fluorouracil—pancreatic cancer	0.00192	0.0116	CcSEcCtD
Ephedrine—Sweating—Tamoxifen—pancreatic cancer	0.00177	0.0108	CcSEcCtD
Ephedrine—Blood pressure increased—Docetaxel—pancreatic cancer	0.00161	0.00978	CcSEcCtD
Ephedrine—Irritability—Fluorouracil—pancreatic cancer	0.00155	0.00939	CcSEcCtD
Ephedrine—Arrhythmia—Tamoxifen—pancreatic cancer	0.00148	0.009	CcSEcCtD
Ephedrine—Arrhythmia—Erlotinib—pancreatic cancer	0.00147	0.0089	CcSEcCtD
Ephedrine—Bradycardia—Sunitinib—pancreatic cancer	0.00145	0.00878	CcSEcCtD
Ephedrine—Lightheadedness—Docetaxel—pancreatic cancer	0.00144	0.00875	CcSEcCtD
Ephedrine—Angina pectoris—Irinotecan—pancreatic cancer	0.00143	0.00865	CcSEcCtD
Ephedrine—Muscle spasms—Tamoxifen—pancreatic cancer	0.00139	0.00843	CcSEcCtD
Ephedrine—Angina pectoris—Fluorouracil—pancreatic cancer	0.00137	0.00828	CcSEcCtD
Ephedrine—Arrhythmia—Sunitinib—pancreatic cancer	0.00127	0.0077	CcSEcCtD
Ephedrine—Delirium—Epirubicin—pancreatic cancer	0.00127	0.00767	CcSEcCtD
Ephedrine—Sweating—Irinotecan—pancreatic cancer	0.00125	0.00759	CcSEcCtD
Ephedrine—Hypertension—Tamoxifen—pancreatic cancer	0.00125	0.00757	CcSEcCtD
Ephedrine—Chest pain—Tamoxifen—pancreatic cancer	0.00123	0.00746	CcSEcCtD
Ephedrine—Anxiety—Tamoxifen—pancreatic cancer	0.00123	0.00744	CcSEcCtD
Ephedrine—Sweating—Gemcitabine—pancreatic cancer	0.00122	0.00739	CcSEcCtD
Ephedrine—Chest pain—Erlotinib—pancreatic cancer	0.00122	0.00738	CcSEcCtD
Ephedrine—Anxiety—Erlotinib—pancreatic cancer	0.00121	0.00736	CcSEcCtD
Ephedrine—Bradycardia—Irinotecan—pancreatic cancer	0.00119	0.00723	CcSEcCtD
Ephedrine—Muscle spasms—Sunitinib—pancreatic cancer	0.00119	0.00722	CcSEcCtD
Ephedrine—Delirium—Doxorubicin—pancreatic cancer	0.00117	0.0071	CcSEcCtD
Ephedrine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00114	0.00692	CcSEcCtD
Ephedrine—Anorexia—Tamoxifen—pancreatic cancer	0.00113	0.00682	CcSEcCtD
Ephedrine—Anorexia—Erlotinib—pancreatic cancer	0.00111	0.00675	CcSEcCtD
Ephedrine—Hypertension—Sunitinib—pancreatic cancer	0.00107	0.00648	CcSEcCtD
Ephedrine—Insomnia—Tamoxifen—pancreatic cancer	0.00107	0.00647	CcSEcCtD
Ephedrine—Insomnia—Erlotinib—pancreatic cancer	0.00106	0.0064	CcSEcCtD
Ephedrine—Chest pain—Sunitinib—pancreatic cancer	0.00105	0.00639	CcSEcCtD
Ephedrine—Dyspnoea—Tamoxifen—pancreatic cancer	0.00105	0.00638	CcSEcCtD
Ephedrine—Arrhythmia—Irinotecan—pancreatic cancer	0.00105	0.00635	CcSEcCtD
Ephedrine—Dyspnoea—Erlotinib—pancreatic cancer	0.00104	0.00631	CcSEcCtD
Ephedrine—Dyspepsia—Tamoxifen—pancreatic cancer	0.00104	0.0063	CcSEcCtD
Ephedrine—Dyspepsia—Erlotinib—pancreatic cancer	0.00103	0.00623	CcSEcCtD
Ephedrine—Decreased appetite—Tamoxifen—pancreatic cancer	0.00103	0.00622	CcSEcCtD
Ephedrine—Arrhythmia—Gemcitabine—pancreatic cancer	0.00102	0.00618	CcSEcCtD
Ephedrine—Decreased appetite—Erlotinib—pancreatic cancer	0.00102	0.00615	CcSEcCtD
Ephedrine—Pain—Tamoxifen—pancreatic cancer	0.00101	0.00612	CcSEcCtD
Ephedrine—Arrhythmia—Fluorouracil—pancreatic cancer	0.001	0.00608	CcSEcCtD
Ephedrine—Pain—Erlotinib—pancreatic cancer	0.000999	0.00605	CcSEcCtD
Ephedrine—Angina pectoris—Docetaxel—pancreatic cancer	0.000986	0.00598	CcSEcCtD
Ephedrine—Muscle spasms—Irinotecan—pancreatic cancer	0.000981	0.00595	CcSEcCtD
Ephedrine—Anorexia—Sunitinib—pancreatic cancer	0.000964	0.00584	CcSEcCtD
Ephedrine—Body temperature increased—Erlotinib—pancreatic cancer	0.000924	0.0056	CcSEcCtD
Ephedrine—Vertigo—Irinotecan—pancreatic cancer	0.000917	0.00556	CcSEcCtD
Ephedrine—Insomnia—Sunitinib—pancreatic cancer	0.000915	0.00554	CcSEcCtD
Ephedrine—Dyspnoea—Sunitinib—pancreatic cancer	0.000902	0.00546	CcSEcCtD
Ephedrine—Dyspepsia—Sunitinib—pancreatic cancer	0.00089	0.00539	CcSEcCtD
Ephedrine—Hypertension—Irinotecan—pancreatic cancer	0.000881	0.00534	CcSEcCtD
Ephedrine—Decreased appetite—Sunitinib—pancreatic cancer	0.000879	0.00533	CcSEcCtD
Ephedrine—Pain—Sunitinib—pancreatic cancer	0.000865	0.00524	CcSEcCtD
Ephedrine—Hypertension—Gemcitabine—pancreatic cancer	0.000858	0.0052	CcSEcCtD
Ephedrine—Asthenia—Tamoxifen—pancreatic cancer	0.000847	0.00513	CcSEcCtD
Ephedrine—Chest pain—Gemcitabine—pancreatic cancer	0.000846	0.00513	CcSEcCtD
Ephedrine—Confusional state—Irinotecan—pancreatic cancer	0.00084	0.00509	CcSEcCtD
Ephedrine—Asthenia—Erlotinib—pancreatic cancer	0.000838	0.00508	CcSEcCtD
Ephedrine—Chest pain—Fluorouracil—pancreatic cancer	0.000832	0.00504	CcSEcCtD
Ephedrine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000805	0.00488	CcSEcCtD
Ephedrine—Confusional state—Fluorouracil—pancreatic cancer	0.000804	0.00487	CcSEcCtD
Ephedrine—Body temperature increased—Sunitinib—pancreatic cancer	0.000799	0.00484	CcSEcCtD
Ephedrine—Anorexia—Irinotecan—pancreatic cancer	0.000794	0.00481	CcSEcCtD
Ephedrine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000784	0.00475	CcSEcCtD
Ephedrine—Dizziness—Tamoxifen—pancreatic cancer	0.000781	0.00473	CcSEcCtD
Ephedrine—Tachycardia—Fluorouracil—pancreatic cancer	0.000779	0.00472	CcSEcCtD
Ephedrine—Anorexia—Gemcitabine—pancreatic cancer	0.000774	0.00469	CcSEcCtD
Ephedrine—Dizziness—Erlotinib—pancreatic cancer	0.000773	0.00468	CcSEcCtD
Ephedrine—Anorexia—Fluorouracil—pancreatic cancer	0.000761	0.00461	CcSEcCtD
Ephedrine—Insomnia—Irinotecan—pancreatic cancer	0.000753	0.00457	CcSEcCtD
Ephedrine—Vomiting—Tamoxifen—pancreatic cancer	0.000751	0.00455	CcSEcCtD
Ephedrine—Rash—Tamoxifen—pancreatic cancer	0.000745	0.00451	CcSEcCtD
Ephedrine—Dermatitis—Tamoxifen—pancreatic cancer	0.000744	0.00451	CcSEcCtD
Ephedrine—Vomiting—Erlotinib—pancreatic cancer	0.000743	0.0045	CcSEcCtD
Ephedrine—Dyspnoea—Irinotecan—pancreatic cancer	0.000743	0.0045	CcSEcCtD
Ephedrine—Headache—Tamoxifen—pancreatic cancer	0.00074	0.00448	CcSEcCtD
Ephedrine—Rash—Erlotinib—pancreatic cancer	0.000737	0.00446	CcSEcCtD
Ephedrine—Dermatitis—Erlotinib—pancreatic cancer	0.000736	0.00446	CcSEcCtD
Ephedrine—Insomnia—Gemcitabine—pancreatic cancer	0.000734	0.00445	CcSEcCtD
Ephedrine—Dyspepsia—Irinotecan—pancreatic cancer	0.000733	0.00444	CcSEcCtD
Ephedrine—Headache—Erlotinib—pancreatic cancer	0.000732	0.00443	CcSEcCtD
Ephedrine—Asthenia—Sunitinib—pancreatic cancer	0.000726	0.0044	CcSEcCtD
Ephedrine—Decreased appetite—Irinotecan—pancreatic cancer	0.000724	0.00439	CcSEcCtD
Ephedrine—Arrhythmia—Docetaxel—pancreatic cancer	0.000724	0.00439	CcSEcCtD
Ephedrine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000723	0.00438	CcSEcCtD
Ephedrine—Insomnia—Fluorouracil—pancreatic cancer	0.000722	0.00437	CcSEcCtD
Ephedrine—Pain—Irinotecan—pancreatic cancer	0.000712	0.00432	CcSEcCtD
Ephedrine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000711	0.00431	CcSEcCtD
Ephedrine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000705	0.00427	CcSEcCtD
Ephedrine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000702	0.00426	CcSEcCtD
Ephedrine—Nausea—Tamoxifen—pancreatic cancer	0.000701	0.00425	CcSEcCtD
Ephedrine—Pain—Gemcitabine—pancreatic cancer	0.000694	0.0042	CcSEcCtD
Ephedrine—Nausea—Erlotinib—pancreatic cancer	0.000694	0.0042	CcSEcCtD
Ephedrine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000694	0.0042	CcSEcCtD
Ephedrine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000686	0.00416	CcSEcCtD
Ephedrine—Pain—Fluorouracil—pancreatic cancer	0.000682	0.00413	CcSEcCtD
Ephedrine—Muscle spasms—Docetaxel—pancreatic cancer	0.000678	0.00411	CcSEcCtD
Ephedrine—Dizziness—Sunitinib—pancreatic cancer	0.000669	0.00405	CcSEcCtD
Ephedrine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000669	0.00405	CcSEcCtD
Ephedrine—Angina pectoris—Epirubicin—pancreatic cancer	0.000665	0.00403	CcSEcCtD
Ephedrine—Body temperature increased—Irinotecan—pancreatic cancer	0.000659	0.00399	CcSEcCtD
Ephedrine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000657	0.00398	CcSEcCtD
Ephedrine—Vomiting—Sunitinib—pancreatic cancer	0.000643	0.0039	CcSEcCtD
Ephedrine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000641	0.00389	CcSEcCtD
Ephedrine—Dysuria—Epirubicin—pancreatic cancer	0.000639	0.00387	CcSEcCtD
Ephedrine—Rash—Sunitinib—pancreatic cancer	0.000638	0.00386	CcSEcCtD
Ephedrine—Dermatitis—Sunitinib—pancreatic cancer	0.000637	0.00386	CcSEcCtD
Ephedrine—Headache—Sunitinib—pancreatic cancer	0.000634	0.00384	CcSEcCtD
Ephedrine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000631	0.00382	CcSEcCtD
Ephedrine—Palpitations—Docetaxel—pancreatic cancer	0.000624	0.00378	CcSEcCtD
Ephedrine—Angina pectoris—Doxorubicin—pancreatic cancer	0.000616	0.00373	CcSEcCtD
Ephedrine—Hypertension—Docetaxel—pancreatic cancer	0.000609	0.00369	CcSEcCtD
Ephedrine—Chest pain—Docetaxel—pancreatic cancer	0.000601	0.00364	CcSEcCtD
Ephedrine—Nausea—Sunitinib—pancreatic cancer	0.000601	0.00364	CcSEcCtD
Ephedrine—Asthenia—Irinotecan—pancreatic cancer	0.000598	0.00362	CcSEcCtD
Ephedrine—Dysuria—Doxorubicin—pancreatic cancer	0.000591	0.00358	CcSEcCtD
Ephedrine—Sweating—Epirubicin—pancreatic cancer	0.000584	0.00354	CcSEcCtD
Ephedrine—Asthenia—Gemcitabine—pancreatic cancer	0.000582	0.00353	CcSEcCtD
Ephedrine—Confusional state—Docetaxel—pancreatic cancer	0.000581	0.00352	CcSEcCtD
Ephedrine—Tachycardia—Docetaxel—pancreatic cancer	0.000562	0.00341	CcSEcCtD
Ephedrine—Bradycardia—Epirubicin—pancreatic cancer	0.000557	0.00337	CcSEcCtD
Ephedrine—Dizziness—Irinotecan—pancreatic cancer	0.000551	0.00334	CcSEcCtD
Ephedrine—Anorexia—Docetaxel—pancreatic cancer	0.000549	0.00333	CcSEcCtD
Ephedrine—Sweating—Doxorubicin—pancreatic cancer	0.00054	0.00327	CcSEcCtD
Ephedrine—Vomiting—Irinotecan—pancreatic cancer	0.00053	0.00321	CcSEcCtD
Ephedrine—Dizziness—Fluorouracil—pancreatic cancer	0.000528	0.0032	CcSEcCtD
Ephedrine—Rash—Irinotecan—pancreatic cancer	0.000525	0.00318	CcSEcCtD
Ephedrine—Dermatitis—Irinotecan—pancreatic cancer	0.000525	0.00318	CcSEcCtD
Ephedrine—Headache—Irinotecan—pancreatic cancer	0.000522	0.00316	CcSEcCtD
Ephedrine—Insomnia—Docetaxel—pancreatic cancer	0.000521	0.00316	CcSEcCtD
Ephedrine—Vomiting—Gemcitabine—pancreatic cancer	0.000516	0.00313	CcSEcCtD
Ephedrine—Bradycardia—Doxorubicin—pancreatic cancer	0.000515	0.00312	CcSEcCtD
Ephedrine—Dyspnoea—Docetaxel—pancreatic cancer	0.000513	0.00311	CcSEcCtD
Ephedrine—Rash—Gemcitabine—pancreatic cancer	0.000512	0.0031	CcSEcCtD
Ephedrine—Dermatitis—Gemcitabine—pancreatic cancer	0.000511	0.0031	CcSEcCtD
Ephedrine—Headache—Gemcitabine—pancreatic cancer	0.000508	0.00308	CcSEcCtD
Ephedrine—Vomiting—Fluorouracil—pancreatic cancer	0.000507	0.00307	CcSEcCtD
Ephedrine—Dyspepsia—Docetaxel—pancreatic cancer	0.000507	0.00307	CcSEcCtD
Ephedrine—Rash—Fluorouracil—pancreatic cancer	0.000503	0.00305	CcSEcCtD
Ephedrine—Dermatitis—Fluorouracil—pancreatic cancer	0.000503	0.00305	CcSEcCtD
Ephedrine—Decreased appetite—Docetaxel—pancreatic cancer	0.000501	0.00303	CcSEcCtD
Ephedrine—Headache—Fluorouracil—pancreatic cancer	0.0005	0.00303	CcSEcCtD
Ephedrine—Nausea—Irinotecan—pancreatic cancer	0.000495	0.003	CcSEcCtD
Ephedrine—Pain—Docetaxel—pancreatic cancer	0.000492	0.00298	CcSEcCtD
Ephedrine—Arrhythmia—Epirubicin—pancreatic cancer	0.000488	0.00296	CcSEcCtD
Ephedrine—Nausea—Gemcitabine—pancreatic cancer	0.000482	0.00292	CcSEcCtD
Ephedrine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000475	0.00288	CcSEcCtD
Ephedrine—Nausea—Fluorouracil—pancreatic cancer	0.000474	0.00287	CcSEcCtD
Ephedrine—Tension—Epirubicin—pancreatic cancer	0.000467	0.00283	CcSEcCtD
Ephedrine—Nervousness—Epirubicin—pancreatic cancer	0.000462	0.0028	CcSEcCtD
Ephedrine—Muscle spasms—Epirubicin—pancreatic cancer	0.000458	0.00277	CcSEcCtD
Ephedrine—Body temperature increased—Docetaxel—pancreatic cancer	0.000455	0.00276	CcSEcCtD
Ephedrine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000452	0.00274	CcSEcCtD
Ephedrine—Agitation—Epirubicin—pancreatic cancer	0.000437	0.00265	CcSEcCtD
Ephedrine—Tension—Doxorubicin—pancreatic cancer	0.000432	0.00262	CcSEcCtD
Ephedrine—Nervousness—Doxorubicin—pancreatic cancer	0.000428	0.00259	CcSEcCtD
Ephedrine—Vertigo—Epirubicin—pancreatic cancer	0.000428	0.00259	CcSEcCtD
Ephedrine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000423	0.00257	CcSEcCtD
Ephedrine—Palpitations—Epirubicin—pancreatic cancer	0.000421	0.00255	CcSEcCtD
Ephedrine—Asthenia—Docetaxel—pancreatic cancer	0.000413	0.0025	CcSEcCtD
Ephedrine—Hypertension—Epirubicin—pancreatic cancer	0.000411	0.00249	CcSEcCtD
Ephedrine—Chest pain—Epirubicin—pancreatic cancer	0.000405	0.00245	CcSEcCtD
Ephedrine—Agitation—Doxorubicin—pancreatic cancer	0.000405	0.00245	CcSEcCtD
Ephedrine—Anxiety—Epirubicin—pancreatic cancer	0.000404	0.00245	CcSEcCtD
Ephedrine—Vertigo—Doxorubicin—pancreatic cancer	0.000396	0.0024	CcSEcCtD
Ephedrine—Confusional state—Epirubicin—pancreatic cancer	0.000392	0.00237	CcSEcCtD
Ephedrine—Palpitations—Doxorubicin—pancreatic cancer	0.000389	0.00236	CcSEcCtD
Ephedrine—Dizziness—Docetaxel—pancreatic cancer	0.000381	0.00231	CcSEcCtD
Ephedrine—Hypertension—Doxorubicin—pancreatic cancer	0.00038	0.0023	CcSEcCtD
Ephedrine—Tachycardia—Epirubicin—pancreatic cancer	0.000379	0.0023	CcSEcCtD
Ephedrine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000375	0.00228	CcSEcCtD
Ephedrine—Chest pain—Doxorubicin—pancreatic cancer	0.000375	0.00227	CcSEcCtD
Ephedrine—Anxiety—Doxorubicin—pancreatic cancer	0.000374	0.00226	CcSEcCtD
Ephedrine—Anorexia—Epirubicin—pancreatic cancer	0.00037	0.00224	CcSEcCtD
Ephedrine—Vomiting—Docetaxel—pancreatic cancer	0.000366	0.00222	CcSEcCtD
Ephedrine—Rash—Docetaxel—pancreatic cancer	0.000363	0.0022	CcSEcCtD
Ephedrine—Dermatitis—Docetaxel—pancreatic cancer	0.000363	0.0022	CcSEcCtD
Ephedrine—Confusional state—Doxorubicin—pancreatic cancer	0.000362	0.0022	CcSEcCtD
Ephedrine—Headache—Docetaxel—pancreatic cancer	0.000361	0.00219	CcSEcCtD
Ephedrine—Insomnia—Epirubicin—pancreatic cancer	0.000351	0.00213	CcSEcCtD
Ephedrine—Tachycardia—Doxorubicin—pancreatic cancer	0.000351	0.00213	CcSEcCtD
Ephedrine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000347	0.00211	CcSEcCtD
Ephedrine—Dyspnoea—Epirubicin—pancreatic cancer	0.000346	0.0021	CcSEcCtD
Ephedrine—Anorexia—Doxorubicin—pancreatic cancer	0.000343	0.00208	CcSEcCtD
Ephedrine—Nausea—Docetaxel—pancreatic cancer	0.000342	0.00207	CcSEcCtD
Ephedrine—Dyspepsia—Epirubicin—pancreatic cancer	0.000342	0.00207	CcSEcCtD
Ephedrine—Decreased appetite—Epirubicin—pancreatic cancer	0.000338	0.00205	CcSEcCtD
Ephedrine—Pain—Epirubicin—pancreatic cancer	0.000332	0.00201	CcSEcCtD
Ephedrine—Insomnia—Doxorubicin—pancreatic cancer	0.000325	0.00197	CcSEcCtD
Ephedrine—Dyspnoea—Doxorubicin—pancreatic cancer	0.00032	0.00194	CcSEcCtD
Ephedrine—Feeling abnormal—Epirubicin—pancreatic cancer	0.00032	0.00194	CcSEcCtD
Ephedrine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000316	0.00192	CcSEcCtD
Ephedrine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000312	0.00189	CcSEcCtD
Ephedrine—Pain—Doxorubicin—pancreatic cancer	0.000307	0.00186	CcSEcCtD
Ephedrine—Body temperature increased—Epirubicin—pancreatic cancer	0.000307	0.00186	CcSEcCtD
Ephedrine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000296	0.00179	CcSEcCtD
Ephedrine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000284	0.00172	CcSEcCtD
Ephedrine—Asthenia—Epirubicin—pancreatic cancer	0.000279	0.00169	CcSEcCtD
Ephedrine—Asthenia—Doxorubicin—pancreatic cancer	0.000258	0.00156	CcSEcCtD
Ephedrine—Dizziness—Epirubicin—pancreatic cancer	0.000257	0.00156	CcSEcCtD
Ephedrine—Vomiting—Epirubicin—pancreatic cancer	0.000247	0.0015	CcSEcCtD
Ephedrine—Rash—Epirubicin—pancreatic cancer	0.000245	0.00148	CcSEcCtD
Ephedrine—Dermatitis—Epirubicin—pancreatic cancer	0.000245	0.00148	CcSEcCtD
Ephedrine—Headache—Epirubicin—pancreatic cancer	0.000243	0.00147	CcSEcCtD
Ephedrine—Dizziness—Doxorubicin—pancreatic cancer	0.000238	0.00144	CcSEcCtD
Ephedrine—Nausea—Epirubicin—pancreatic cancer	0.000231	0.0014	CcSEcCtD
Ephedrine—Vomiting—Doxorubicin—pancreatic cancer	0.000229	0.00138	CcSEcCtD
Ephedrine—Rash—Doxorubicin—pancreatic cancer	0.000227	0.00137	CcSEcCtD
Ephedrine—Dermatitis—Doxorubicin—pancreatic cancer	0.000226	0.00137	CcSEcCtD
Ephedrine—Headache—Doxorubicin—pancreatic cancer	0.000225	0.00136	CcSEcCtD
Ephedrine—Nausea—Doxorubicin—pancreatic cancer	0.000213	0.00129	CcSEcCtD
Ephedrine—ADRA1A—Signaling by GPCR—CCK—pancreatic cancer	0.000102	0.000796	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—DPYD—pancreatic cancer	0.000102	0.000795	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SSTR1—pancreatic cancer	0.000101	0.000786	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CNR2—pancreatic cancer	9.94e-05	0.000775	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GLP1R—pancreatic cancer	9.94e-05	0.000775	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPY—pancreatic cancer	9.88e-05	0.000771	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CCKAR—pancreatic cancer	9.78e-05	0.000763	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SSTR2—pancreatic cancer	9.7e-05	0.000757	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—IAPP—pancreatic cancer	9.7e-05	0.000756	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—SLC2A2—pancreatic cancer	9.68e-05	0.000755	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ZNRF3—pancreatic cancer	9.61e-05	0.00075	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—ACVR1B—pancreatic cancer	9.61e-05	0.00075	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	9.58e-05	0.000747	CbGpPWpGaD
Ephedrine—ACHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	9.55e-05	0.000745	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CNR1—pancreatic cancer	9.5e-05	0.000741	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.47e-05	0.000738	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCKBR—pancreatic cancer	9.37e-05	0.000731	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—SST—pancreatic cancer	9.35e-05	0.000729	CbGpPWpGaD
Ephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	9.32e-05	0.000727	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PTHLH—pancreatic cancer	9.31e-05	0.000726	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GLP1R—pancreatic cancer	9.25e-05	0.000721	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	9.24e-05	0.000721	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—GCG—pancreatic cancer	9.17e-05	0.000715	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—DPYD—pancreatic cancer	9.1e-05	0.00071	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—SHH—pancreatic cancer	8.92e-05	0.000695	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—DTX4—pancreatic cancer	8.81e-05	0.000687	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GLI1—pancreatic cancer	8.81e-05	0.000687	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—IAPP—pancreatic cancer	8.81e-05	0.000687	CbGpPWpGaD
Ephedrine—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	8.75e-05	0.000683	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AGTR1—pancreatic cancer	8.75e-05	0.000683	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DTX1—pancreatic cancer	8.69e-05	0.000678	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SSTR3—pancreatic cancer	8.69e-05	0.000678	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—SLC2A2—pancreatic cancer	8.63e-05	0.000673	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CNR1—pancreatic cancer	8.63e-05	0.000673	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NRP1—pancreatic cancer	8.57e-05	0.000668	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PPP2R5B—pancreatic cancer	8.57e-05	0.000668	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.54e-05	0.000666	CbGpPWpGaD
Ephedrine—BCHE—Transmission across Chemical Synapses—HRAS—pancreatic cancer	8.52e-05	0.000665	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—SST—pancreatic cancer	8.51e-05	0.000664	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTHLH—pancreatic cancer	8.45e-05	0.000659	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PTCH1—pancreatic cancer	8.45e-05	0.000659	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	8.42e-05	0.000657	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	8.35e-05	0.000651	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SSTR1—pancreatic cancer	8.33e-05	0.00065	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—GCG—pancreatic cancer	8.33e-05	0.00065	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HEY2—pancreatic cancer	8.25e-05	0.000643	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.25e-05	0.000643	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPY—pancreatic cancer	8.17e-05	0.000638	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GAST—pancreatic cancer	8.06e-05	0.000628	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SSTR2—pancreatic cancer	8.02e-05	0.000626	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AGTR1—pancreatic cancer	7.95e-05	0.00062	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CNR1—pancreatic cancer	7.86e-05	0.000613	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCKBR—pancreatic cancer	7.75e-05	0.000604	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—SST—pancreatic cancer	7.73e-05	0.000603	CbGpPWpGaD
Ephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	7.71e-05	0.000601	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SCT—pancreatic cancer	7.64e-05	0.000596	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HEY1—pancreatic cancer	7.64e-05	0.000596	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	7.61e-05	0.000593	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—GCG—pancreatic cancer	7.59e-05	0.000592	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.51e-05	0.000586	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—CD44—pancreatic cancer	7.49e-05	0.000585	CbGpPWpGaD
Ephedrine—ADRA1A—G alpha (q) signalling events—PIK3CA—pancreatic cancer	7.38e-05	0.000576	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.34e-05	0.000572	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—MMP2—pancreatic cancer	7.33e-05	0.000572	CbGpPWpGaD
Ephedrine—ACHE—Neuronal System—HRAS—pancreatic cancer	7.32e-05	0.000571	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—DTX4—pancreatic cancer	7.29e-05	0.000568	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCK—pancreatic cancer	7.29e-05	0.000568	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GLI1—pancreatic cancer	7.29e-05	0.000568	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.27e-05	0.000567	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AGTR1—pancreatic cancer	7.24e-05	0.000565	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	7.19e-05	0.000561	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—GCG—pancreatic cancer	7.19e-05	0.00056	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CNR1—pancreatic cancer	7.13e-05	0.000556	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CNR2—pancreatic cancer	7.1e-05	0.000554	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GLP1R—pancreatic cancer	7.1e-05	0.000554	CbGpPWpGaD
Ephedrine—ADRB2—GPCR ligand binding—CXCL8—pancreatic cancer	7.1e-05	0.000553	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NRP1—pancreatic cancer	7.09e-05	0.000553	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PPP2R5B—pancreatic cancer	7.09e-05	0.000553	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCKAR—pancreatic cancer	6.98e-05	0.000545	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—GCG—pancreatic cancer	6.89e-05	0.000537	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HEY2—pancreatic cancer	6.82e-05	0.000532	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAG2—pancreatic cancer	6.77e-05	0.000528	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—STK11—pancreatic cancer	6.76e-05	0.000527	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—CD44—pancreatic cancer	6.69e-05	0.000521	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MEN1—pancreatic cancer	6.68e-05	0.000521	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GAST—pancreatic cancer	6.66e-05	0.00052	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	6.6e-05	0.000515	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AGTR1—pancreatic cancer	6.57e-05	0.000513	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.55e-05	0.000511	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—MMP2—pancreatic cancer	6.54e-05	0.00051	CbGpPWpGaD
Ephedrine—BCHE—Neuronal System—HRAS—pancreatic cancer	6.53e-05	0.000509	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.49e-05	0.000506	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—GCG—pancreatic cancer	6.41e-05	0.0005	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SHH—pancreatic cancer	6.37e-05	0.000497	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.34e-05	0.000495	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH4—pancreatic cancer	6.33e-05	0.000494	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SCT—pancreatic cancer	6.32e-05	0.000493	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HEY1—pancreatic cancer	6.32e-05	0.000493	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—IAPP—pancreatic cancer	6.29e-05	0.00049	CbGpPWpGaD
Ephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	6.11e-05	0.000476	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CXCL8—pancreatic cancer	6.09e-05	0.000475	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTHLH—pancreatic cancer	6.04e-05	0.000471	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTCH1—pancreatic cancer	6.04e-05	0.000471	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—STK11—pancreatic cancer	6.03e-05	0.00047	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCK—pancreatic cancer	6.03e-05	0.00047	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CNR2—pancreatic cancer	5.87e-05	0.000458	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GLP1R—pancreatic cancer	5.87e-05	0.000458	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR ligand binding—CXCL8—pancreatic cancer	5.87e-05	0.000458	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—TYMS—pancreatic cancer	5.81e-05	0.000453	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCKAR—pancreatic cancer	5.78e-05	0.000451	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.66e-05	0.000441	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of proteins—CTNNB1—pancreatic cancer	5.62e-05	0.000438	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAG2—pancreatic cancer	5.6e-05	0.000437	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SST—pancreatic cancer	5.52e-05	0.000431	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MEN1—pancreatic cancer	5.52e-05	0.000431	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CG—pancreatic cancer	5.45e-05	0.000425	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CXCL8—pancreatic cancer	5.44e-05	0.000424	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—JAG1—pancreatic cancer	5.4e-05	0.000421	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH3—pancreatic cancer	5.38e-05	0.00042	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SHH—pancreatic cancer	5.27e-05	0.000411	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH4—pancreatic cancer	5.23e-05	0.000408	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—IAPP—pancreatic cancer	5.2e-05	0.000406	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—TYMS—pancreatic cancer	5.18e-05	0.000404	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CNR1—pancreatic cancer	5.1e-05	0.000397	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of proteins—CTNNB1—pancreatic cancer	5.02e-05	0.000391	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTHLH—pancreatic cancer	4.99e-05	0.000389	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTCH1—pancreatic cancer	4.99e-05	0.000389	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CG—pancreatic cancer	4.95e-05	0.000386	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—GCG—pancreatic cancer	4.92e-05	0.000384	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CD—pancreatic cancer	4.79e-05	0.000373	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—APOE—pancreatic cancer	4.73e-05	0.000369	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AGTR1—pancreatic cancer	4.69e-05	0.000366	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STK11—pancreatic cancer	4.63e-05	0.000361	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SST—pancreatic cancer	4.57e-05	0.000356	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CG—pancreatic cancer	4.5e-05	0.000351	CbGpPWpGaD
Ephedrine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.47e-05	0.000349	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—JAG1—pancreatic cancer	4.47e-05	0.000349	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH3—pancreatic cancer	4.45e-05	0.000347	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CD—pancreatic cancer	4.35e-05	0.000339	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CG—pancreatic cancer	4.27e-05	0.000333	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—APOE—pancreatic cancer	4.22e-05	0.000329	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CNR1—pancreatic cancer	4.21e-05	0.000329	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CB—pancreatic cancer	4.17e-05	0.000325	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PPARG—pancreatic cancer	4.12e-05	0.000321	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CG—pancreatic cancer	4.09e-05	0.000319	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—GCG—pancreatic cancer	4.07e-05	0.000317	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SMAD4—pancreatic cancer	4.05e-05	0.000316	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—CXCL8—pancreatic cancer	4.01e-05	0.000313	CbGpPWpGaD
Ephedrine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.99e-05	0.000311	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CD—pancreatic cancer	3.96e-05	0.000309	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HES1—pancreatic cancer	3.96e-05	0.000309	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AGTR1—pancreatic cancer	3.88e-05	0.000303	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STK11—pancreatic cancer	3.83e-05	0.000298	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CG—pancreatic cancer	3.81e-05	0.000297	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CB—pancreatic cancer	3.79e-05	0.000296	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CD—pancreatic cancer	3.75e-05	0.000292	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PPARG—pancreatic cancer	3.67e-05	0.000286	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—CXCL8—pancreatic cancer	3.64e-05	0.000284	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CD—pancreatic cancer	3.6e-05	0.00028	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TERT—pancreatic cancer	3.47e-05	0.00027	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CB—pancreatic cancer	3.45e-05	0.000269	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SMAD4—pancreatic cancer	3.35e-05	0.000261	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CD—pancreatic cancer	3.35e-05	0.000261	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—CXCL8—pancreatic cancer	3.32e-05	0.000259	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HIF1A—pancreatic cancer	3.32e-05	0.000259	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TSC2—pancreatic cancer	3.31e-05	0.000258	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HES1—pancreatic cancer	3.27e-05	0.000255	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CB—pancreatic cancer	3.27e-05	0.000255	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTGS2—pancreatic cancer	3.24e-05	0.000253	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—APOE—pancreatic cancer	3.24e-05	0.000252	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KDR—pancreatic cancer	3.17e-05	0.000247	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CB—pancreatic cancer	3.13e-05	0.000244	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NFKBIA—pancreatic cancer	3.02e-05	0.000235	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—CXCL8—pancreatic cancer	3.01e-05	0.000235	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NOTCH1—pancreatic cancer	2.99e-05	0.000233	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CG—pancreatic cancer	2.92e-05	0.000228	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—NRAS—pancreatic cancer	2.92e-05	0.000228	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CB—pancreatic cancer	2.92e-05	0.000227	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTGS2—pancreatic cancer	2.89e-05	0.000225	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGF—pancreatic cancer	2.89e-05	0.000225	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	2.87e-05	0.000224	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PTEN—pancreatic cancer	2.82e-05	0.00022	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	2.74e-05	0.000214	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	2.74e-05	0.000213	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	2.68e-05	0.000209	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—EGFR—pancreatic cancer	2.66e-05	0.000208	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	2.62e-05	0.000205	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CD—pancreatic cancer	2.57e-05	0.0002	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.54e-05	0.000198	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PTEN—pancreatic cancer	2.52e-05	0.000197	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—KRAS—pancreatic cancer	2.51e-05	0.000196	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	2.49e-05	0.000195	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	2.47e-05	0.000193	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	2.42e-05	0.000188	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	2.42e-05	0.000188	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	2.39e-05	0.000186	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—PIK3CA—pancreatic cancer	2.31e-05	0.00018	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CB—pancreatic cancer	2.24e-05	0.000175	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	2.2e-05	0.000172	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CXCL8—pancreatic cancer	2.15e-05	0.000168	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—HRAS—pancreatic cancer	2.14e-05	0.000167	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	2.12e-05	0.000166	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	2.1e-05	0.000164	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	2.08e-05	0.000162	CbGpPWpGaD
Ephedrine—ADRB2—GPCR downstream signaling—AKT1—pancreatic cancer	2.08e-05	0.000162	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CASP3—pancreatic cancer	2.06e-05	0.000161	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CCND1—pancreatic cancer	2e-05	0.000156	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—PIK3CA—pancreatic cancer	1.99e-05	0.000155	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—CTNNB1—pancreatic cancer	1.98e-05	0.000155	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MMP9—pancreatic cancer	1.95e-05	0.000152	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PTEN—pancreatic cancer	1.93e-05	0.000151	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	1.91e-05	0.000149	CbGpPWpGaD
Ephedrine—ADRB2—Signaling by GPCR—AKT1—pancreatic cancer	1.89e-05	0.000147	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	1.85e-05	0.000144	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—SRC—pancreatic cancer	1.79e-05	0.00014	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	1.78e-05	0.000139	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—PIK3CA—pancreatic cancer	1.78e-05	0.000139	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	1.77e-05	0.000138	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—VEGFA—pancreatic cancer	1.75e-05	0.000136	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—STAT3—pancreatic cancer	1.73e-05	0.000135	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—NRAS—pancreatic cancer	1.73e-05	0.000135	CbGpPWpGaD
Ephedrine—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	1.72e-05	0.000134	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	1.7e-05	0.000133	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	1.66e-05	0.000129	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	1.64e-05	0.000128	CbGpPWpGaD
Ephedrine—ACHE—Metabolism—AKT1—pancreatic cancer	1.63e-05	0.000127	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	1.61e-05	0.000126	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—MYC—pancreatic cancer	1.61e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TGFB1—pancreatic cancer	1.6e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	1.6e-05	0.000125	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—EGFR—pancreatic cancer	1.57e-05	0.000123	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	1.56e-05	0.000122	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—KRAS—pancreatic cancer	1.49e-05	0.000116	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	1.48e-05	0.000116	CbGpPWpGaD
Ephedrine—BCHE—Metabolism—AKT1—pancreatic cancer	1.45e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	1.45e-05	0.000113	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	1.43e-05	0.000112	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	1.43e-05	0.000111	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—PIK3CA—pancreatic cancer	1.36e-05	0.000106	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	1.33e-05	0.000104	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	1.33e-05	0.000103	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—TP53—pancreatic cancer	1.32e-05	0.000103	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	1.3e-05	0.000101	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—HRAS—pancreatic cancer	1.26e-05	9.85e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	1.23e-05	9.58e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	1.13e-05	8.8e-05	CbGpPWpGaD
Ephedrine—ADRB2—Signaling Pathways—AKT1—pancreatic cancer	1.11e-05	8.69e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	1.09e-05	8.52e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	1.04e-05	8.14e-05	CbGpPWpGaD
Ephedrine—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	9.22e-06	7.19e-05	CbGpPWpGaD
